574662 Sigma-AldrichSurvivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem
The Survivin Inhibitor, YM155, also referenced under CAS 781661-94-7, controls the biological activity of Survivin.
More>> The Survivin Inhibitor, YM155, also referenced under CAS 781661-94-7, controls the biological activity of Survivin. Less<<Sinónimos: Survivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| CAS # | Empirical Formula |
|---|---|
| 781661-94-7 | C₂₀H₁₉BrN₄O₃ |
| References | |
|---|---|
| References | Nakamura, N., et al. 2012. Mol. Cell. Proteomics. 11, M111.0132434. Tolcher, A.W., et al. 2008, J. Clin. Oncol. 26, 5198. Nakahara, T., et al. 2007, Cancer Res. 67, 8014. |
| Product Information | |
|---|---|
| CAS number | 781661-94-7 |
| Form | Yellow solid |
| Hill Formula | C₂₀H₁₉BrN₄O₃ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Interleukin enhancer-binding factor 3 (ILF3/NF110) |
| Primary Target IC<sub>50</sub> | 540nM |
| Secondary target | Unknown |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 574662 | 0 |
Documentation
Survivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem Ficha datos de seguridad (MSDS)
| Título |
|---|
Survivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem Certificados de análisis
| Cargo | Número de lote |
|---|---|
| 574662 |
Referencias bibliográficas
| Visión general referencias |
|---|
| Nakamura, N., et al. 2012. Mol. Cell. Proteomics. 11, M111.0132434. Tolcher, A.W., et al. 2008, J. Clin. Oncol. 26, 5198. Nakahara, T., et al. 2007, Cancer Res. 67, 8014. |



